|
|
L B Margolis, S Glushakova, J C Grivel, P M Murphy
J Clin Invest. 1998;
101(9):1876
doi:10.1172/JCI2015
Abstract |
Full text
| PDF
T
he CC chemokines MIP-1alpha, MIP-1beta, and RANTES suppress replication of certain HIV-1 strains in cultured PBMC and T cell lines by blocking interaction of gp120 with CC chemokine receptor 5 (CCR5). However, the same chemokines can enhance HIV-1 replication in cultured macrophages. The net effect of chemokines on HIV-1 infection in intact lymphoid tissue, the major reservoir of HIV-1 in vivo, is unknown and unpredictable since the tissue contains both T lymphocytes and macrophages. Here we show that exogenous MIP-1alpha, MIP-1beta, and RANTES markedly suppressed replication of CCR5-tropic HIV-1 strains in blocks of human lymphoid tissue infected ex vivo. Moreover, endogenous MIP-1alpha, MIP-1beta, and RANTES were upregulated in tissues infected ex vivo with CXC chemokine receptor 4-tropic but not CCR5-tropic HIV-1. Such an upregulation may contribute to the virus phenotype shift in the course of HIV disease in vivo.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.
Julie M Decker, Kenneth P Zammit, Juliet L Easlick, Mario L Santiago, Denise Bonenberger, Beatrice H Hahn, Olaf Kutsch, Frederic Bibollet-Ruche
|
Virology
|
2009 |
Comparison CCR5del32 Mutation in the CCR5 Gene Frequencies in Russians, Tuvinians, and in Groups of HIV-Infected Individuals
S. A. Apryatin, E. R. Rakhmanaliev, I. A. Nikolaeva, S. V. Ruban, F. G. Vazykhova, E. A. Klimov, G. E. Sulimova, I. G. Sidorovich
|
Russ J Genet
|
2005 |
Therapieoptionen bei HIV
J. Röling, R. Draenert, F. D. Goebel
|
Internist
|
2005 |
The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection
Thomas Lehner
|
Trends in Immunology
|
2002 |
Chemokines and their receptors in infectious disease
David H. McDermott, Philip M. Murphy
|
Springer Semin Immunopathol
|
2000 |
Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection
Caterina Lapenta, Monica Boirivant, Marco Marini, Stefano M. Santini, Mariantonia Logozzi, Marina Viora, Filippo Belardelli, Stefano Fais
|
Eur. J. Immunol.
|
1999 |
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
Svetlana Glushakova, Yanjie Yi, Jean-Charles Grivel, Anjali Singh, Dominique Schols, Erik De Clercq, Ronald G. Collman, Leonid Margolis
|
J. Clin. Invest.
|
1999 |
Restriction of HIV Type 1 Infection in Macrophages Heterozygous for a Deletion in the CC-Chemokine Receptor 5 Gene
Lucia Ometto, Marisa Zanchetta, Anna Cabrelle, Giovanni Esposito, Monica Mainardi, Luigi Chieco-Bianchi, Anita De Rossi
|
AIDS Research and Human Retroviruses
|
1999 |
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
Edward A. Berger, Philip M. Murphy, Joshua M. Farber
|
Annu. Rev. Immunol.
|
1999 |
CHEMOKINES AND CHEMOKINE RECEPTORS: Biology and Clinical Relevance in Inflammation and AIDS1
Massimo Locati, MD, Philip M. Murphy, MD
|
Annu. Rev. Med.
|
1999 |
|
